Coronavirus

Infectious Disease·MeSH: Coronavirus Infections

14 drugs in development·12 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
paxlovid	PFIZER INC (PFE)
tofidence	BIOGEN INC. (BIIB)

Phase 3(3)

Phase 2(3)

Drug	Company
Celecoxib	UNITED THERAPEUTICS Corp (UTHR)
Famotidine	UNITED THERAPEUTICS Corp (UTHR)
ino-4700	INOVIO PHARMACEUTICALS, INC. (INO)

Phase 1(2)

Drug	Company
hydroxychloroquine sar321068	Sanofi (SNY)
oravax oral vaccine	ORAMED PHARMACEUTICALS INC. (ORMP)

Preclinical(2)

Drug	Company
cov	Decoy Therapeutics Inc. (DCOY)
sbfm-pl4	SUNSHINE BIOPHARMA INC. (SBFM)

Unknown(1)

Drug	Company
diphenhydramine	Mesoblast Limited (MESO)

Phase 1/Phase 2(1)

Drug	Company
CYNK-001	Celularity Inc. (CELU)

BioSniper tracks 14 drugs in development for Coronavirus across 12 companies.

There are 3 clinical trials targeting Coronavirus tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.